Sulfur burps with Ozempic® are burps that carry a rotten-egg smell, and they are one of the more unpleasant digestive side effects people report on this class of medicine. Ozempic® (semaglutide) is approved to manage blood sugar in type 2 diabetes, to reduce cardiovascular risk and to slow kidney disease progression — and the same molecule is sold as Wegovy® for weight management. All of these medicines slow how quickly the stomach empties, which is exactly why the smell happens.
The good news is that this side effect is measurable, manageable and usually temporary. Belching appears in the prescribing information for every GLP-1 medicine, which means we can say how common it actually is instead of guessing. Below you will find those numbers, what helps, what does not, how sulfur burps relate to the nausea many people get on Ozempic®, and the specific warning signs that mean it is time to call your prescriber rather than wait it out.
Sulfur burps are burps accompanied by a foul, rotten-egg smell. That smell is hydrogen sulfide, a gas produced when bacteria in the digestive tract break down proteins that contain sulfur — eggs, meat, dairy, garlic, onions and cruciferous vegetables such as broccoli and cabbage.
Ozempic® and the other GLP-1 medicines slow gastric emptying. That is not a malfunction; it is part of how they work, since food staying longer in the stomach is what makes you feel full sooner and for longer. The side effect is that sulfur-rich food also has more time to sit and ferment before it moves on, so more hydrogen sulfide is produced and more of it comes back up as a burp.
Not everyone on Ozempic® gets sulfur burps, and the reasons are multifactorial. Other medications, existing digestive conditions, how quickly your dose was increased and what you ate that day all play a part. Anyone experiencing sulfur burps should mention them to their healthcare provider, who can give advice tailored to the whole picture and, if needed, adjust the dose or the schedule.
This question used to have no good answer. It does now. Every current FDA-approved prescribing information reports eructation — the clinical word for belching — in its table of adverse reactions, alongside rates for placebo. Here is what the labels say.
| Medicine | Belching reported in trials | Placebo |
|---|---|---|
| Ozempic® (semaglutide injection) | 2.7% on 0.5 mg; 1.1% on 1 mg | 0% |
| Wegovy® (semaglutide 2.4 mg injection) | 7% | under 1% |
| Rybelsus® (oral semaglutide) | about 2% on 14 mg | — |
| Mounjaro® (tirzepatide) | 3.0% / 2.5% / 3.3% on 5, 10 and 15 mg | 0.4% |
| Zepbound® (tirzepatide) | 4% / 5% / 5% on 5, 10 and 15 mg | 1% |
| Foundayo® (orforglipron tablets) | 6% / 8% / 8% on 5.5, 9 and 17.2 mg | 1% |
One honest caveat: the labels record belching, not the smell of it. Sulfur burps are a subset of these numbers, not the whole of them.
Belching reported in clinical trials (highest dose studied)
Put plainly: roughly one person in fourteen on Wegovy® reported belching in trials, against fewer than one in a hundred on placebo. It is common enough to be expected and uncommon enough that most people never get it.
Yes. Because every medicine in this class slows gastric emptying, every one of them can produce the same effect. If you are weighing one against another, our comparisons of Zepbound® versus Wegovy® and Mounjaro® versus Ozempic® cover the wider differences. On this particular side effect, switching brands is not a reliable fix on its own, and it is a decision for your prescriber rather than a self-experiment.
Three medicines have arrived since this article was first written, and all of them can cause belching:
Yes. Anything that slows the digestive tract can produce the same result, because the mechanism is the same: food lingers, bacteria ferment it, hydrogen sulfide builds up. Opioid painkillers are the clearest example. Metformin commonly causes digestive upset of its own, and acid-reducing medicines such as omeprazole change the stomach environment in ways that can encourage bacterial overgrowth in some people.
If you take several of these together, the effect can stack. That is worth raising with your prescriber, who may adjust a dose, change the timing of a medication, or suggest an alternative — none of which you should do on your own.
Diet matters a great deal, because the raw material for the smell is sulfur-containing food: meat, eggs, dairy, legumes, and vegetables such as broccoli, cabbage, cauliflower, garlic and onions. Combine a large helping of those with a stomach that is emptying slowly and you have the recipe for sulfur burps. Our guide to foods to avoid on Ozempic® covers this in more detail.
One important correction to the usual advice: the answer is not to eat less protein. A 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society puts adequate protein and strength training at the center of GLP-1 care, because weight lost on these medicines includes muscle unless you protect it. Spread protein across smaller meals through the day rather than eating a large amount at one sitting. That reduces the fermentation load without shorting your body on what it needs.
Fat is the other lever. Fatty meals slow gastric emptying further, on top of what the medication is already doing, so lighter and lower-fat meals tend to be easier. Eating slowly helps too, since gulping swallows air and adds to the volume of gas.
No remedy switches sulfur burps off instantly. The ones worth trying are the ones that work on the cause — less material fermenting for less time.
This is the most-searched remedy for sulfur burps, and it is also the only one with a published mechanism behind it. Bismuth binds hydrogen sulfide directly. In a 1998 study in the journal Gastroenterology, ten healthy adults took bismuth subsalicylate 524 mg four times a day for three to seven days, and hydrogen sulfide release from the colon fell by more than 95%.
Two honest limits: that study measured gas in the colon rather than burps, and it was not done in anyone taking a GLP-1. It is suggestive, not proof.
The cautions matter as much as the effect. Bismuth subsalicylate contains a salicylate, which means it is not for anyone with an aspirin allergy, anyone taking blood thinners, or children and teenagers with a viral illness, because of the risk of Reye’s syndrome. It also temporarily turns the tongue and stool black — harmless, but alarming if nobody warned you. Clear it with your prescriber before you start.
These come up constantly, and they all aim at the wrong target. Antacids neutralize stomach acid. Simethicone (Gas-X®) breaks up gas bubbles. Acid blockers such as omeprazole reduce acid production. None of them removes hydrogen sulfide, which is the actual source of the smell.
They are not useless — they are simply for a different problem. If your dominant symptom is heartburn or reflux rather than the smell, a 2026 clinical review of GLP-1 digestive effects supports using acid suppression for that, under your prescriber’s guidance.
The first step is the dietary and lifestyle work above. When that is not enough, the conversation moves to the medication itself, and the prescribing information gives providers clear room to work with.
If you want the full picture of how these medicines are stepped up, our semaglutide dosage chart and tirzepatide dosing guide lay out the standard schedules.
Less predictably than you might think. It is reasonable to assume a higher dose means more slowing and more burping, and for some medicines the label bears that out: Zepbound® rises from 4% at 5 mg to 5% at 15 mg, and Foundayo® from 6% to 8%. But Ozempic®’s own label shows belching in 2.7% of people on 0.5 mg and only 1.1% on 1 mg — the opposite of a dose-response.
What the evidence points to instead is change. Digestive side effects cluster during dose escalation, when the body is adjusting to a new level, and settle as treatment continues at a steady dose. That is why holding a dose usually works better than dropping the medication.
These two travel together often enough that people search for them as a pair. The reason is mechanical: the same delayed emptying that lets food sit and ferment eventually sends a larger, less thoroughly digested load downstream, which can loosen stools. Similar territory to constipation on Ozempic® — different symptom, same underlying change in how fast things move.
The important part is knowing where the line is. Occasional loose stools alongside burping is a tolerability problem to manage. Vomiting or diarrhea severe enough that you cannot keep fluids down is different: the prescribing information for these medicines warns about dehydration and, in some reported cases, acute kidney injury serious enough to require dialysis. That is a call to your prescriber the same day, not a wait-and-see.
There is no published timeline for sulfur burps specifically, and any article that gives you a confident number is making it up. What the prescribing information does say is that gastrointestinal reactions are most frequent during dose escalation and generally become less common as treatment continues.
In practice that means most people find the symptom eases within a few weeks at a steady dose, and that the four-week dose hold described above is usually what gets them there. If it has not improved after a full cycle at the same dose, that is the point to go back to your prescriber rather than keep enduring it.
Usually not. Sulfur burps on a GLP-1 are far more often a consequence of slowed digestion than a sign of disease. For scale, a 2026 study of nearly 165,000 people taking GLP-1 medicines, matched against the same number of people who were not, found that about 32% had some digestive side effect within a year, while serious problems remained rare: gastroparesis in 0.7% and drug-induced pancreatitis in 0.05%.
Rare is not never, though, and some symptoms deserve prompt attention.
Call your prescriber if sulfur burps come with any of these:
• Severe or persistent abdominal pain, especially pain that spreads through to your back — this can signal pancreatitis.
• Pain in the upper right abdomen with fever, nausea or yellowing of the skin or eyes — this can signal gallbladder disease.
• Bloating and vomiting with no bowel movement — this can signal a blocked or paralyzed bowel.
• Vomiting or diarrhea severe enough that you cannot keep fluids down — dehydration on these medicines can affect the kidneys.
• Symptoms that persist despite dietary changes and a dose hold — worth investigating other causes.
When sulfur burps persist and the medication does not explain them, the older suspects are still worth ruling out: a gastrointestinal infection such as giardiasis, small intestinal bacterial overgrowth (SIBO), or gastroesophageal reflux disease (GERD). Each has its own workup, and each is treatable.
This is the part of the conversation that matters most and gets discussed least. In November 2024 the FDA added a warning about pulmonary aspiration — stomach contents entering the lungs — to the labels of GLP-1 medicines, following reports during general anesthesia and deep sedation. A stomach that is still emptying slowly may not be empty when a procedure assumes it is.
In October 2024, five medical societies including the American Society of Anesthesiologists and the American Gastroenterological Association published joint guidance on this. Most patients continue their medication before elective procedures. Patients considered higher risk are those still increasing their dose, those on higher doses, and those with active digestive symptoms — who are advised to take liquids only for the 24 hours beforehand.
If you are getting sulfur burps, you have an active digestive symptom. Tell your surgeon, endoscopist or anesthesia team which medicine you take, what dose you are on, and what symptoms you are having, well before the day. It is a short conversation that changes how they prepare.
Stopping is not a withdrawal in the way people often imagine. There is no withdrawal syndrome with these medicines and no tapering requirement. What happens is that gastric emptying gradually returns toward its normal speed, and the digestive side effects that came with slowing it — including sulfur burps — generally fade rather than flare.
What does return is appetite, and with it weight regain for most people, along with rising blood sugar for those taking it for type 2 diabetes. Our article on what happens when you stop taking Ozempic® covers that in full. It is also worth knowing that restarting later usually means beginning again at a low dose and titrating up, because tolerance to the digestive effects fades along with everything else.
Any decision to change or stop a medication belongs with your prescriber, who can plan it around your blood sugar, your weight and what comes next.
Belching and sulfur burps are rarely the reason a patient calls, but they are often the reason a patient quietly stops taking the medication. A short, specific plan at the point of prescribing tends to protect adherence better than reassurance after the fact.
Structured protocols for prescribing, dosing, titration, monitoring and side-effect management are the core of IAPAM’s GLP-1 certification training for weight management providers, available online and in person.
Semaglutide and tirzepatide changed what patients expect from their providers. IAPAM’s GLP-1 certification gives you the protocols, titration schedules, monitoring parameters and side-effect management to run a medically supervised weight management program with confidence.
What the certification covers
For MD/DO, NP, APRN, PA, RN and other licensed providers
Online — self-paced
6 CMEs · 7–10 hours · 24/7 access
In person — Scottsdale, AZ
9 CMEs · 1-day intensive · body contouring included
Questions? Call 1-866-211-6901
Belching is a recognized side effect of semaglutide and every other GLP-1 medicine, and the prescribing information reports how often it happened in clinical trials: 2.7% of people on Ozempic® 0.5 mg, 7% on Wegovy® 2.4 mg, and 4% to 5% on Zepbound®. What the labels record is belching, not its smell, so the rotten-egg version is a subset of those numbers. It is unpleasant rather than dangerous, and it most often shows up while the dose is being increased.
Nothing switches them off instantly, but the measures that help most work on the cause: smaller and lower-fat meals so the stomach empties sooner, spreading sulfur-rich foods across the day instead of eating a large amount at one sitting, eating slowly, staying hydrated, and stopping when you first feel full. Bismuth subsalicylate binds hydrogen sulfide, the gas behind the smell, and is the only over-the-counter option with a published mechanism. Ask your prescriber before adding it.
It may, and there is a reason to think so. In a 1998 study published in Gastroenterology, ten healthy adults took bismuth subsalicylate 524 mg four times a day for three to seven days, and hydrogen sulfide release from the colon fell by more than 95%. That study measured gas in the colon rather than burps, it was small, and it was not done in anyone taking a GLP-1. Bismuth subsalicylate contains a salicylate, so it is not appropriate for people with an aspirin allergy, anyone taking blood thinners, or children and teenagers with a viral illness. It also temporarily turns the tongue and stool black, which is harmless but alarming if you are not expecting it. Check with your prescriber first.
There is no published timeline for sulfur burps specifically. What the prescribing information does say is that gastrointestinal side effects are most frequent while the dose is being increased and generally become less common as treatment continues. If a dose is not tolerated, the labels allow the prescriber to stay at that dose for another four weeks before stepping up, which is often what settles the symptom.
Yes. Belching appears in the prescribing information for every medicine in this class, because they all slow gastric emptying to some degree. In trials it was reported by 4% to 5% of people on Zepbound®, 2.5% to 3.3% on Mounjaro®, 7% on Wegovy® and 6% to 8% on the newer oral medicine Foundayo®, against about 1% on placebo. Switching from one to another is not a reliable fix on its own, and is a decision for your prescriber.
Call your prescriber when sulfur burps come with severe or persistent abdominal pain, especially pain that spreads to the back; pain in the upper right abdomen with fever or yellowing of the skin or eyes; bloating and vomiting with no bowel movement; or vomiting and diarrhea bad enough that you cannot keep fluids down. Also tell any surgeon, endoscopist or anesthesia team about your medicine and dose before a procedure, because slowed stomach emptying matters for sedation.
Sulfur burps are an unwelcome but well-recognized part of GLP-1 treatment, and for most people they are a passing phase of dose escalation rather than a reason to abandon a medication that is working. Smaller and lower-fat meals, protein spread through the day, a slower titration and a conversation with your prescriber will resolve the great majority of cases. The symptoms that deserve urgency are the ones listed above — severe pain, jaundice, an unmoving bowel, or dehydration — and none of them are subtle.
For providers, side-effect management is one of the clinical skills that separates a weight management program patients stay with from one they quietly abandon. IAPAM’s GLP-1 certification training covers protocols, titration and monitoring for semaglutide and tirzepatide in both online and in-person formats. You can also browse the rest of our Medical Weight Management® Library for patient questions we answer in the same detail.
Disclaimer: This article is for informational and educational purposes only and does not constitute medical advice. It is not a substitute for the guidance of your own prescriber, who can account for your full medical history, medications and treatment goals. Never start, stop, change the dose of, or add anything to a prescription medication without speaking to a qualified, licensed healthcare provider.
Medical Weight Management Training
Build the clinical, operational, and business foundations to evaluate GLP-1 weight-management services for your practice—without handing your patient relationships to a corporate intermediary.
Explore GLP-1 Certification Training →Want to add Botox® training to your broader practice plan? Explore IAPAM’s Botox training options →
In order to have a successful aesthetic practice, you need to have effective advertising to attract people to your business.
This includes spending those
While Ozempic® has been proven effective in clinical trials, a potential reason for not losing weight on Ozempic® is related to dietary and lifestyle choices.
Failure to refrigerate the Ozempic® within the correct temperature range may result in reduced effectiveness and potential harm to the user.
Learn about the effects of stopping Ozempic® for diabetes & weight loss. Manage withdrawal & maintain health gains.
Request your Quick Start Checklist for Starting or Integrating a New GLP-1 for Weight Loss Guide.
Terms and conditions apply. Offer expires October 31.